These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1522823)

  • 1. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
    Gump DW; Nadeau OW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):131-43. PubMed ID: 1522823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
    Pitz AM; Park GW; Lee D; Boissy YL; Vinjé J
    Gut Microbes; 2015; 6(2):93-100. PubMed ID: 25901890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of bismuth by Yersinia enterocolitica.
    Nadeau OW; Gump DW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):145-52. PubMed ID: 1522824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
    Mahony DE; Woods A; Eelman MD; Burford N; Veldhuyzen van Zanten SJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):431-3. PubMed ID: 15616328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
    Rambout L; Sahai J; Gallicano K; Oliveras L; Garber G
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2187-90. PubMed ID: 7811043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bismuth subsalicylate: history, chemistry, and safety.
    Bierer DW
    Rev Infect Dis; 1990; 12 Suppl 1():S3-8. PubMed ID: 2406853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
    Kocoshis SA; Ghent CN; Gryboski JD
    Dig Dis Sci; 1984 Dec; 29(12):1148-52. PubMed ID: 6499633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and killing of bacteria by bismuth subsalicylate.
    Sox TE; Olson CA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2075-82. PubMed ID: 2694949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
    Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
    Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bismuth subsalicylate on fecal microflora.
    Gorbach SL; Cornick NA; Silva M
    Rev Infect Dis; 1990; 12 Suppl 1():S21-3. PubMed ID: 2305174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress, diet and alcohol-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate.
    Bagchi D; Carryl OR; Tran MX; Krohn RL; Bagchi DJ; Garg A; Bagchi M; Mitra S; Stohs SJ
    J Appl Toxicol; 1998; 18(1):3-13. PubMed ID: 9526828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.
    Kappstein I; Engels I
    Eur J Clin Microbiol; 1987 Apr; 6(2):216-7. PubMed ID: 3595590
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin.
    Horowitz NS; Staats HF; Palker TJ
    Immunopharmacology; 1995 Nov; 31(1):31-41. PubMed ID: 8655289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.
    Ericsson CD; Evans DG; DuPont HL; Evans DJ; Pickering LK
    J Infect Dis; 1977 Nov; 136(5):693-6. PubMed ID: 335003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
    León-Barúa R; Tello-Casanova R
    Acta Gastroenterol Latinoam; 1985; 15(3):157-64. PubMed ID: 3836544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).
    Pickering LK; Feldman S; Ericsson CD; Cleary TG
    J Pediatr; 1981 Oct; 99(4):654-6. PubMed ID: 7277115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.